Innovative BioTherapies News & Updates

Stay up to date with the latest developments from Innovative BioTherapies and follow our ongoing work advancing extracorporeal therapies and innovative critical care solutions designed to improve outcomes in severe inflammatory and organ failure conditions.

image-title

Immunomodulatory Device to Treat Pediatric Patients with Severe Sepsis and/or Multiorgan Failure

May 2, 2026

Acute kidney injury (AKI) is a serious condition that may lead to severe deterioration in kidney function, oftentimes resulting in multiorgan failure.

Read More

First-of-its-kind therapeutic device saves child

First-of-its-kind therapeutic device saves child

Created by Michigan Medicine, the first-in-class immune cell directed therapeutic device could be a breakthrough in the fight against deadly infections in kids

New device can treat injury from sepsis

New device can treat injury from sepsis

Prior to February 2024, limited therapeutics were available to treat sepsis, a life threatening organ dysfunction caused by a dysregulated host response to infection.

U-M research-based technology receives FDA Humanitarian Device Exemption for pediatric kidney injury treatment

U-M research-based technology receives FDA Humanitarian Device Exemption for pediatric kidney injury treatment

“The SCD-PED provides an extraordinary new type of treatment for pediatric patients experiencing acute kidney failure,”